A print friendly PDF version is available from this Communicable Diseases Intelligence issue's table of contents.
During the three month period of the Campaign, the uptake of measles-mumps-rubella (MMR) vaccine given at primary school clinics and the number of adverse events following MMR vaccination are being monitored. Data are forwarded to the National Centre for Disease Control for collation and publication in CDI.
Measles Control Campaign activity data, cumulative to 25 September 19981
|Sum total students||902,261|
|Total forms returned||832,214|
|Consents to vaccinate||697,287|
|Total students immunised||651,615|
|Of total students||93% returned their forms|
|Of total forms returned||84% consented to vaccination|
|Of total consents to vaccination||95% have been vaccinated|
|Of total students||72% have been vaccinated|
|Local allergic reaction||2|
|Severe immediate local reaction||1|
|Myalgia/Lymphadenopathy/ headache/stiff neck/rash||1|
|Immediate acute unilateral parotitis||1|
1. Victorian data are not included in the activity data report, but are included in the adverse events report.
Enquiries can be directed to Sue Campbell-Lloyd, National Manager of the Measles Control Campaign, Sydney Office, Commonwealth Department of Health and Aged Care, PO Box 9848, Sydney 2000, phone (02) 9263 3990, E-mail Sue.Campbell-Lloyd@health.gov.au.
This article was published in Communicable Diseases Intelligence Volume 22, No 11, 29 October 1998.